FSD Pharma Closes CAD$16.4 Million Sale of Non-core Assets

FSD Pharma Closes CAD$16.4 Million Sale of Non-core Assets

FSD Pharma (HUGE) sold its assets related to cannabis processing to focus on biotech. The C$16.4M in proceeds give the company enough capital to support operations through 2025.

PDF of article